These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 422287)

  • 1. Effect of cobra venom factor on the response of Wistar-Furth rats to the Gross-virus-induced (C58NT)D lymphoma.
    Mizoguchi Y; Osler AG
    Int Arch Allergy Appl Immunol; 1979; 58(3):302-12. PubMed ID: 422287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum complement changes in W/Fu rats inoculated with syngeneic (C58NT) D lymphoma cells.
    Lew FT; Yukiyama Y; Osler AG
    Int Arch Allergy Appl Immunol; 1977; 55(1-6):297-308. PubMed ID: 591098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Passive transfer of systemic tumor immunity with cells generated in vitro by a secondary immune response to a syngeneic rat gross virus-induced lymphoma.
    Bernstein ID
    J Immunol; 1977 Jan; 118(1):122-8. PubMed ID: 830744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressor mechanisms in neonatally acquired tolerance to a Gross virus-induced lymphoma in rats.
    Myburgh JA; Mitchison NA
    Transplantation; 1976 Sep; 22(3):236-44. PubMed ID: 135385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation of cell-mediated cytotoxicity against syngeneic Gross virus-induced lymphoma in rats by phytohemagglutinin and endotoxin.
    Glaser M; Djeu JY; Kirchner H; Herberman RB
    J Immunol; 1976 Jun; 116(6):1512-9. PubMed ID: 774985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of cobra venom factor-induced depletion of serum C3 in eight different strains of mice.
    Finnie JA; Stewart RB; Aston WP
    Dev Comp Immunol; 1981; 5(4):697-701. PubMed ID: 6797851
    [No Abstract]   [Full Text] [Related]  

  • 7. Generation of cytotoxic lymphocytes in vitro: response of immune rat spleen cells to a syngeneic gross virus-induced lymphoma in mixed lymphocyte-tumor culture.
    Bernstein ID; Wright PW; Cohen E
    J Immunol; 1976 May; 116(5):1367-72. PubMed ID: 58029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergy in proliferative and cytotoxic responses of WF rats to syngeneic Gross virus-induced lymphoma cells in vitro.
    Wright PW; Loop SM; Bernstein ID
    J Natl Cancer Inst; 1980 Feb; 64(2):303-8. PubMed ID: 6965510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary cell-mediated cytotoxic response to challenge of rats with syngeneic Gross virus-induced lymphoma.
    Glaser M; Herberman R
    J Natl Cancer Inst; 1976 Jun; 56(6):1211-5. PubMed ID: 62841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo protection against syngeneic Gross virus-induced lymphoma in rats: comparison with in vitro studies of cell-mediated immunity.
    Glaser M; Lavrin DH; Herberman RB
    J Immunol; 1976 Jun; 116(6):1507-11. PubMed ID: 58036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-dependent cellular cytotoxicity to a syngeneic Gross virus-induced lymphoma.
    Ortiz de Landazuri M; Kedar E; Fahey JL
    J Natl Cancer Inst; 1974 Jan; 52(1):147-52. PubMed ID: 4204244
    [No Abstract]   [Full Text] [Related]  

  • 12. Study of the cellular immune response to Gross virus-induced lymphoma by the mixed lymphocyte-tumor interaction.
    Glaser M; Herberman RB; Kirchner H; Djeu JY
    Cancer Res; 1974 Sep; 34(9):2165-71. PubMed ID: 4276482
    [No Abstract]   [Full Text] [Related]  

  • 13. Complement and myoblast transfer therapy: donor myoblast survival is enhanced following depletion of host complement C3 using cobra venom factor, but not in the absence of C5.
    Hodgetts SI; Grounds MD
    Immunol Cell Biol; 2001 Jun; 79(3):231-9. PubMed ID: 11380675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro generation of secondary cell-mediated cytotoxic response against a syngeneic Gross virus-induced lymphoma in rats.
    Glaser M; Bonnard GD; Herberman RB
    J Immunol; 1976 Feb; 116(2):430-6. PubMed ID: 1082456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific enhancement of tumor growth and depression of cell-mediated immunity following sensitization to soluble tumor antigens.
    Rao VS; Bonavida B
    Cancer Res; 1976 Apr; 36(4):1384-91. PubMed ID: 56998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct comparison of three isotopic release microtoxicity assays as measures of cell-mediated immunity to Gross virus-induced lymphomas in rats.
    Oldham RK; Ortaldo JR; Holden HT; Herberman RB
    J Natl Cancer Inst; 1977 Apr; 58(4):1061-7. PubMed ID: 300436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Participation of three lymphoid cell types in the in vitro activation of cell-mediated immunity to a syngeneic gross virus-induced lymphoma in rats.
    Djeu JY; Glaser M; Huang KY; Herberman RB
    Cell Immunol; 1976 May; 23(2):268-77. PubMed ID: 1084228
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of in vitro lymphoproliferative responses to tumor-associated antigens by suppressor cells from rats bearing progressively growing Gross leukemia virus-induced tumors.
    Glaser M; Kirchner H; Herberman RB
    Int J Cancer; 1975 Sep; 16(3):384-93. PubMed ID: 1176200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response to Gross virus-induced lymphoma: comparison of two in vitro assays of cell-mediated immunity.
    Wright PW; Ortiz de Landazuri M; Herberman RB
    J Natl Cancer Inst; 1973 Apr; 50(4):947-54. PubMed ID: 4574190
    [No Abstract]   [Full Text] [Related]  

  • 20. Evidence for long-lasting tumor immunity in a syngeneic rat lymphoma model: correlation of in vitro findings with in vivo observations.
    Oehler JR; Herberman RB
    J Natl Cancer Inst; 1979 Mar; 62(3):525-9. PubMed ID: 153984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.